You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

locally advanced HNSCC

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Head and Neck Squamous Cell Carcinoma, Neoadjuvant Therapy Trial in Wuhan (drug, procedure, radiation)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Neoadjuvant Therapy
  • 3cycles (Toripalimab + cetuximab)
  • +2 more
  • Wuhan, Hebei, China
    Union Hospital, Tongji Medical College, Huazhong University of S
Aug 6, 2023

HNSCC, Radiotherapy, PD-1 Trial in Guangzhou (PD-1inhibitor, concurrent chemoradiotherapy)

Recruiting
  • HNSCC
  • +2 more
  • Guangzhou, Guangdong, China
    Sun yat-sen memorial hospital
Aug 6, 2023

Head and Neck Squamous Cell Carcinoma Trial in Zhuhai (dose-reduced radiotherapy)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • dose-reduced radiotherapy
  • Zhuhai, Guangdong, China
    Fifth Affiliated Hospital of Sun Yat-sen University
May 3, 2023

Squamous Cell Carcinoma of Head and Neck Trial in Charleston (NDURE)

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • NDURE
  • Charleston, South Carolina
    Medical University of South Carolina
May 25, 2022

Head and Neck Squamous Cell Carcinoma Trial (pembrolizumab+cisplatin + 5-fluorouracil)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • pembrolizumab+cisplatin + 5-FU
  • Hangzhou, Zhejiang, China
    Zhejiang Provincial People's Hospital
Dec 26, 2022

Head and Neck Squamous Cell Carcinoma Trial in Germany (Pembrolizumab, Lenvatinib)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Augsburg, BY, Germany
  • +7 more
Jun 20, 2022

Squamous Cell Carcinoma of the Head and Neck Trial in Le Havre (Pembrolizumab, Cetuximab, Radiotherapy)

Active, not recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • Le Havre, France
    Centre Guillaume le conquérant
Aug 18, 2022

Head and Neck Squamous Cell Carcinoma Trial in Guangzhou (drug, procedure, radiation)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Nab-paclitaxel, cisplatin and Pembrolizumab combination
  • +3 more
  • Guangzhou, Guangdong, China
    Guangdong Provincial People's Hospital
Feb 28, 2022

Squamous Cell Carcinoma of Head and Neck, Neoadjuvant Therapy, Resection Margin Trial in Wuhan (Reducing Excision Margins)

Active, not recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • +2 more
  • Reducing Excision Margins
  • Wuhan, Hubei, China
    Zhanjie Zhang
Jul 11, 2022

Head and Neck Squamous Cell Carcinoma Trial (Pembrolizumab, Cisplatin, Paclitaxel-albumin)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • (no location specified)
Oct 25, 2023

Head and Neck Squamous Cell Carcinoma, Neoadjuvant Treatment Trial in Zhuhai (Tislelizumab, Low-dose radiotherapy)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Neoadjuvant Treatment
  • Zhuhai, Guangdong, China
    Fifth Affilliated Hospital of Sun Yat-sen University
Apr 22, 2022

HPV-Related Squamous Cell Carcinoma, Squamous Cell Carcinoma of the Oral Cavity, Squamous Cell Carcinoma of the Larynx Trial in

Not yet recruiting
  • HPV-Related Squamous Cell Carcinoma
  • +4 more
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
Jan 31, 2023

NSCLC, Breast Cancer, HNSCC Trial in Chang chun (YL202 should be intravenously infused)

Not yet recruiting
  • NSCLC
  • +3 more
  • YL202 should be intravenously infused
  • Chang chun, Jilin, China
    Jilin Provincial Cancer Hospital
Oct 25, 2023

ctDNA and/or HPV DNA in High-risk Locally-advanced Head and Neck

Active, not recruiting
  • Cancer
  • +2 more
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Apr 7, 2022

    Squamous Cell Carcinoma of Head and Neck Trial in Chapel Hill, Charleston (biological, drug, radiation)

    Recruiting
    • Squamous Cell Carcinoma of Head and Neck
    • Pembrolizumab
    • +3 more
    • Chapel Hill, North Carolina
    • +1 more
    Oct 25, 2022

    Has a Pathologically Documented Unresectable Locally Advanced or Metastatic Solid Tumor or Lymphoma Trial in Shanghai (Phase I

    Not yet recruiting
    • Has a Pathologically Documented Unresectable Locally Advanced or Metastatic Solid Tumor or Lymphoma
    • Phase I dose escalation
    • +3 more
    • Shanghai, Shanghai, China
      Fudan Cancer Hospital
    Apr 24, 2023

    HNSCC Trial in Chengdu (Nituozumab)

    Recruiting
    • HNSCC
    • Chengdu, Sichuan, China
      Sichuan Cancer Hospital and Research Institute
    Apr 16, 2023

    Locally Advanced Head and Neck Squamous Cell Carcinoma, Neoadjuvant Therapy Trial in Zhuhai (PD-1 inhibitor+ Gemcitabine +

    Recruiting
    • Locally Advanced Head and Neck Squamous Cell Carcinoma
    • Neoadjuvant Therapy
    • PD-1 inhibitor+ Gemcitabine + Cisplatin
    • Zhuhai, Guangdong, China
      Fifth Affilliated Hospital of Sun Yat-sen University
    Jun 23, 2021

    Squamous Cell Carcinoma of Head and Neck Trial in Charleston (NDURE)

    Completed
    Has Results
    • Squamous Cell Carcinoma of Head and Neck
    • NDURE
    • Charleston, South Carolina
      Medical University of South Carolina
    Feb 25, 2021

    Locally Advanced or Metastatic Solid Tumors, NSCLC, HNSCC Trial in Australia, United States (RO7502175, Atezolizumab)

    Recruiting
    • Locally Advanced or Metastatic Solid Tumors
    • +10 more
    • Aurora, Colorado
    • +6 more
    Jan 4, 2023

    Locally Advanced or Metastatic Solid Tumors, Non Small Cell Lung Cancer (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC)

    Not yet recruiting
    • Locally Advanced or Metastatic Solid Tumors
    • +3 more
    • (no location specified)
    Jul 24, 2022

    Head and Neck Squamous Cell Carcinoma Trial (Nimotuzumab Combined With Neoadjuvant Chemotherapy)

    Not yet recruiting
    • Head and Neck Squamous Cell Carcinoma
    • Nimotuzumab Combined With Neoadjuvant Chemotherapy
    • (no location specified)
    Jun 29, 2022

    HNSCC Trial in Lorient (Cetuximab, avelumab, Cisplatin)

    Active, not recruiting
    • HNSCC
    • Lorient, France
      Centre Hospitalier Bretagne Sud
    Mar 10, 2022

    Xerostomia Trial in Stanford (drug, radiation, other)

    Recruiting
    • Xerostomia
    • D-Limonene Gelcaps
    • +3 more
    • Stanford, California
      Stanford University
    Mar 11, 2022

    Head and Neck Squamous Cell Carcinoma, Oral Mucositis Trial in Korea, Republic of, United States (MIT-001 plus CCRT)

    Recruiting
    • Head and Neck Squamous Cell Carcinoma
    • Oral Mucositis
    • MIT-001 plus CCRT
    • Gilbert, Arizona
    • +14 more
    Jan 27, 2022